期刊文献+

合成五种喹唑啉类EGFR-TK抑制剂的新方法 被引量:6

A new approach to synthesizing five quinazolines as EGFR inhibitors
下载PDF
导出
摘要 目的 :表皮生长因子受体酪氨酸激酶 (EGFR TK)是肿瘤治疗的一个新靶点 ,喹唑啉类化合物是一类有效的EGFR TK抑制剂 .其中 ,4 取代苯胺基 6 ,7 二甲氧基喹唑啉被证明有良好的抑制性 .我们改进了这种化合物的合成方法 ,用简单省时的SOCl2 回流法合成五种喹唑啉类EGFR TK抑制剂 .方法 :以 2 氨基 4 ,5 二甲氧基苯甲酸为原料 ,分别经过环化、氯代、取代等反应 ,合成了五种目标化合物 .结果 :经核磁光谱学数据鉴定 ,各中间体及目标产物均与其分子结构相符 .结论 :该合成方法简单、易行 ,操作简便 。 AIM: To synthesize 4 substituted aninine 6,7 dimethoxyl quinazoline, an effective epidermal growth factor receptor tyrosine kinase (EGFR TK) inhibitor. METHODS: A simple and timesaving SOCl 2 refluxed method was adopted to synthesize five quinazoline compounds as EGFR inhibitors. The five quinazoline compounds were prepared by using 2 amino 4,5 dimethoxy benzoic acid as original material, which underwent ring closing, halogenation and substitution. RESULTS: Intermediates and the five quinazolines were characterized by 1H NMR and were found to be in agreement with the corresponding molecular structures. CONCLUSION: This synthetic process is simple, convenient and cost saving.
出处 《第四军医大学学报》 北大核心 2004年第7期613-615,共3页 Journal of the Fourth Military Medical University
关键词 EGFR抑制剂 喹唑啉 SOCl2回流法 化学合成 EGFR inhibitors Quinazoline SOCl 2 reflux method chemical synthesis
  • 相关文献

参考文献5

  • 1[1]Rewcastle GW, Denny WA, Bridges AJ, et al. Synthesis and structure-activity relationships for 4-[(phenylmethyl) amino]- and 4-(phenylamino) quinazolines as potent adenosine 5′-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor[J]. J Med Chem, 1995;38(18):3482-3487.
  • 2[2]Rewcastle GW, Palmer BD, Bridges AJ, et al. Tyrosine kinase inhibitor 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP binding site inhibitor of t he Tyrosine kinase function of the epidermal growth factor receptor[J]. J Med Chem, 1996;39(4):918-928.
  • 3[3]Johnstrom P, Fredriksson A, Thorell JO. Synthesis of [Methoxy-11C]PD153035,A selective EGF Receptor Tyrosine Kinase Inhibitor[J]. J Labelled Cpd Radiopharm, 1998;XLI:623-629.
  • 4[4]Bridges AJ, Zhou HR, Cody DR, et al. Tyrosine kinase inhibitor 8. An unusually steep structure-activity relationships for analogues of 4-(3-bromoanilino) -6,7-dimethoxyquinazoline PD153035, a potent inhibitor of the epidermal growth factor receptor[J]. J Med Chem, 1996;39(1):267-276.
  • 5[5]Smaill JB, Rewcastle GW, Loo JA, et al. Tyrosine kinase inhibitor 17.Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- 4-(phenylamino) pyrido [3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions[J]. J Med Chem, 2000;43(7):1380-1397.

同被引文献70

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部